Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth A Freedberg

Showing results (231-240 of 325) with videos related to

Pageof 33
Sort By:
BMJ Open|July 6, 2022
Development and validation of the age-associated dementia policy (AgeD-Pol) computer simulation model in the USA and EuropeEmily P Hyle, Julia H A Foote, Fatma M Shebl, et al.
American Journal of Respiratory and Critical Care Medicine|May 5, 2026
Cost-Effectiveness of Community Tuberculosis Screening in South AfricaJulie N Deleger, S Nazanin Khatami, Michelle Jones, et al.
The Journal of Infectious Diseases|April 22, 2008
Scaling up antiretroviral therapy in South Africa: the impact of speed on survivalRochelle P Walensky, Robin Wood, Milton C Weinstein, et al.
Journal of the International AIDS Society|April 1, 2016
Survival benefits of antiretroviral therapy in Brazil: a model-based analysisPaula M Luz, Michael P Girouard, Beatriz Grinsztejn, et al.
MDM Policy & Practice|September 25, 2023
The Value-of-Information and Value-of-Implementation from Clinical Trials of Diagnostic Tests for HIV-Associated Tuberculosis: A Modeling AnalysisPamela P Pei, Kieran P Fitzmaurice, Mylinh H Le, et al.
JAMA Internal Medicine|October 5, 2017
Lung Cancer Mortality Associated With Smoking and Smoking Cessation Among People Living With HIV in the United StatesKrishna P Reddy, Chung Yin Kong, Emily P Hyle, et al.
Annals of Internal Medicine|August 29, 2017
Do Less Harm: Evaluating HIV Programmatic Alternatives in Response to Cutbacks in Foreign AidRochelle P Walensky, Ethan D Borre, Linda-Gail Bekker, et al.
Plos One|June 28, 2019
Cost-effectiveness and budget impact of immediate antiretroviral therapy initiation for treatment of HIV infection in Côte d'Ivoire: A model-based analysisEric N Ouattara, Rachel L MacLean, Christine Danel, et al.
The Journal of Infectious Diseases|August 20, 2016
Clinical Impact and Cost-effectiveness of Diagnosing HIV Infection During Early Infancy in South Africa: Test Timing and FrequencyJordan A Francke, Martina Penazzato, Taige Hou, et al.
Archives of Internal Medicine|April 23, 2002
Prophylaxis for human immunodeficiency virus-related Pneumocystis carinii pneumonia: using simulation modeling to inform clinical guidelinesSue J Goldie, Jonathan E Kaplan, Elena Losina, et al.
Pageof 33

Showing results (231-240 of 325) with videos related to

Sort By:
Pageof 33
BMJ Open|July 6, 2022
Development and validation of the age-associated dementia policy (AgeD-Pol) computer simulation model in the USA and EuropeEmily P Hyle, Julia H A Foote, Fatma M Shebl, et al.
American Journal of Respiratory and Critical Care Medicine|May 5, 2026
Cost-Effectiveness of Community Tuberculosis Screening in South AfricaJulie N Deleger, S Nazanin Khatami, Michelle Jones, et al.
The Journal of Infectious Diseases|April 22, 2008
Scaling up antiretroviral therapy in South Africa: the impact of speed on survivalRochelle P Walensky, Robin Wood, Milton C Weinstein, et al.
Journal of the International AIDS Society|April 1, 2016
Survival benefits of antiretroviral therapy in Brazil: a model-based analysisPaula M Luz, Michael P Girouard, Beatriz Grinsztejn, et al.
MDM Policy & Practice|September 25, 2023
The Value-of-Information and Value-of-Implementation from Clinical Trials of Diagnostic Tests for HIV-Associated Tuberculosis: A Modeling AnalysisPamela P Pei, Kieran P Fitzmaurice, Mylinh H Le, et al.
JAMA Internal Medicine|October 5, 2017
Lung Cancer Mortality Associated With Smoking and Smoking Cessation Among People Living With HIV in the United StatesKrishna P Reddy, Chung Yin Kong, Emily P Hyle, et al.
Annals of Internal Medicine|August 29, 2017
Do Less Harm: Evaluating HIV Programmatic Alternatives in Response to Cutbacks in Foreign AidRochelle P Walensky, Ethan D Borre, Linda-Gail Bekker, et al.
Plos One|June 28, 2019
Cost-effectiveness and budget impact of immediate antiretroviral therapy initiation for treatment of HIV infection in Côte d'Ivoire: A model-based analysisEric N Ouattara, Rachel L MacLean, Christine Danel, et al.
The Journal of Infectious Diseases|August 20, 2016
Clinical Impact and Cost-effectiveness of Diagnosing HIV Infection During Early Infancy in South Africa: Test Timing and FrequencyJordan A Francke, Martina Penazzato, Taige Hou, et al.
Archives of Internal Medicine|April 23, 2002
Prophylaxis for human immunodeficiency virus-related Pneumocystis carinii pneumonia: using simulation modeling to inform clinical guidelinesSue J Goldie, Jonathan E Kaplan, Elena Losina, et al.
Pageof 33